Iceland vs Republic of Korea: Hepatitis B surface antigen (HBsAg) prevalence
Iceland
0.0%
in 2024
Republic of Korea
0.0%
in 2024
Iceland rank
132nd
Republic of Korea rank
132nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Iceland
- Republic of Korea
How they compare
Iceland currently reports 0.0% against 0.0% in Republic of Korea, a difference of 0.0%.
Across all 10 years both countries report, Republic of Korea has been ahead every year.
Iceland ranks 132nd and Republic of Korea ranks 132nd of 194 countries.
Republic of Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iceland | Republic of Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.0% | Republic of Korea |
| 2020s | 0.0% | 0.0% | 0.0% | Republic of Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Iceland or Republic of Korea?
- Iceland, at 0.0% against 0.0% in Republic of Korea as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Iceland and Republic of Korea?
- 0.0%, with Iceland ahead.
- How many years of comparable data are there for Iceland and Republic of Korea?
- 10 years are reported by both, from 2015 to 2024.
- How do Iceland and Republic of Korea rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Iceland ranks 132nd and Republic of Korea ranks 132nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.